Melbourne, Nov 7, 2008 AEST (ABN Newswire) - Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), is featured today at the 2008 UBS Australian Healthcare Conference underway in Sydney as one of three leading emerging companies in the biotechnology space.
Executive Director Professor Silviu Itescu will update investors on the clinical and commercial progress of Mesoblast's proprietary adult stem cell platform technology, with regard to disorders of bone and cartilage, cardiovascular diseases, eye diseases and bone marrow transplantation.
In addition, he will brief investors on Mesoblast's stem cell business model, with special focus on recent trends in partnering between adult stem cell companies and the global pharmaceutical industry.
The annual UBS Australian Healthcare Conference is the leading healthcare investor conference in Australia.
Contact
Julie Meldrum
Corporate Communications Director
Mesoblast Limited
T: + 61 (03) 9639 6036
E: julie.meldrum@mesoblast.com
W: www.mesoblast.com
| ||
|
